We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$314B
AUM Growth
-$33.1B
Cap. Flow
+$4.21B
Cap. Flow %
1.34%
Top 10 Hldgs %
30.1%
Holding
11,456
New
1,843
Increased
4,539
Reduced
3,686
Closed
1,300

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.04%
2 Technology 2.01%
3 Communication Services 1.39%
4 Financials 0.98%
5 Consumer Discretionary 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCC
2751
CALL
WESCO International
WCC
$16.4B
$4.26M ﹤0.01%
186,300
+60,100
+48% +$2.56M
SIX
2752
CALL
DELISTED
Six Flags Entertainment Corp.
SIX
$4.25M ﹤0.01%
339,300
-78,000
-19% -$2.32M
RLI icon
2753
RLI Corp
RLI
$5.9B
$4.25M ﹤0.01%
96,742
-136,586
-59% -$6.01M
ICPT
2754
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4.25M ﹤0.01%
67,512
-2,313
-3% -$208K
WCN
2755
CALL
Waste Connections
WCN
$41.7B
$4.25M ﹤0.01%
54,800
-30,800
-36% -$2.89M
CDW icon
2756
CALL
CDW
CDW
$18.5B
$4.24M ﹤0.01%
45,500
-100
-0.2% -$12.2K
EDIT icon
2757
Editas Medicine
EDIT
$485M
$4.24M ﹤0.01%
213,866
-76,779
-26% -$1.94M
CXW icon
2758
PUT
CoreCivic
CXW
$3.34B
$4.24M ﹤0.01%
379,500
-438,500
-54% -$6.57M
ALNY icon
2759
Alnylam Pharmaceuticals
ALNY
$31.7B
$4.23M ﹤0.01%
38,879
+402
+1% +$46.4K
RITM icon
2760
CALL
Rithm Capital
RITM
$5.63B
$4.23M ﹤0.01%
843,700
+477,200
+130% +$6.92M
PETS icon
2761
PUT
PetMed Express
PETS
$40.8M
$4.22M ﹤0.01%
146,800
-118,100
-45% -$3.1M
VRSN icon
2762
VeriSign
VRSN
$26.4B
$4.22M ﹤0.01%
23,436
-2,450
-9% -$482K
BIO icon
2763
Bio-Rad Laboratories Class A
BIO
$10.4B
$4.21M ﹤0.01%
12,006
-3,151
-21% -$1.16M
BAH icon
2764
CALL
Booz Allen Hamilton
BAH
$9.05B
$4.21M ﹤0.01%
61,300
+44,300
+261% +$3.27M
VGK icon
2765
CALL
Vanguard FTSE Europe ETF
VGK
$30.9B
$4.21M ﹤0.01%
97,200
-1,300
-1% -$68.9K
SDY icon
2766
State Street SPDR S&P Dividend ETF
SDY
$22B
$4.2M ﹤0.01%
52,643
+19,464
+59% +$1.92M
BKR icon
2767
CALL
Baker Hughes
BKR
$62B
$4.2M ﹤0.01%
400,300
-428,400
-52% -$8.05M
STE icon
2768
CALL
Steris
STE
$22.8B
$4.2M ﹤0.01%
30,000
+11,800
+65% +$1.76M
SCHV
2769
Schwab US Large-Cap Value ETF
SCHV
$15.8B
$4.19M ﹤0.01%
284,127
+185,352
+188% +$3.4M
QQEW icon
2770
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.88B
$4.19M ﹤0.01%
+67,240
New +$4.8M
DMRL
2771
DELISTED
DeltaShares S&P 500 Managed Risk ETF
DMRL
$4.19M ﹤0.01%
76,586
-370
-0.5% -$22.2K
CHWY icon
2772
Chewy
CHWY
$9.52B
$4.18M ﹤0.01%
111,600
+7,987
+8% +$235K
PLAN
2773
PUT
DELISTED
Anaplan, Inc.
PLAN
$4.18M ﹤0.01%
138,100
-78,700
-36% -$3.92M
CQQQ icon
2774
Invesco China Technology ETF
CQQQ
$3.07B
$4.18M ﹤0.01%
87,247
+83,077
+1,992% +$4.46M
FYX icon
2775
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.39B
$4.17M ﹤0.01%
101,081
+73,036
+260% +$4.13M

Similar funds

Jeff Yass's Q1 2020 Portfolio in Review

As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q1 2020 filing shows 1,843 new, 4,539 increased, 3,686 reduced and 1,300 closed positions. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M. The largest sale was Amazon, an estimated $946M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 89% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
  • Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
  • Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
  • Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
  • Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
  • Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.